Moreover, IL-6-induced tumor growth of HCC cells via STAT3 phosphorylation at tyrosine 705 in the presence of sorafenib is reversed with IL-6Rα depletion (Table 1) [12]. This evidence concerns the gene IL6 and hepatocellular carcinoma.